Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in Invest Ophthalmol Vis Sci

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    June 2019
  1. ASHIMATEY BS, Green KM, Chu Z, Wang RK, et al
    Impaired Retinal Vascular Reactivity in Diabetic Retinopathy as Assessed by Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2019;60:2468-2473.
    PubMed     Text format     Abstract available


  2. CARROLL LS, Uehara H, Fang D, Choi S, et al
    Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina.
    Invest Ophthalmol Vis Sci. 2019;60:2494-2502.
    PubMed     Text format     Abstract available


  3. YAMAMOTO M, Fujihara K, Ishizawa M, Osawa T, et al
    Overt Proteinuria, Moderately Reduced eGFR and Their Combination Are Predictive of Severe Diabetic Retinopathy or Diabetic Macular Edema in Diabetes.
    Invest Ophthalmol Vis Sci. 2019;60:2685-2689.
    PubMed     Text format     Abstract available


    May 2019
  4. LUO Q, Xiao Y, Alex A, Cummins TR, et al
    The Diurnal Rhythm of Insulin Receptor Substrate-1 (IRS-1) and Kir4.1 in Diabetes: Implications for a Clock Gene Bmal1.
    Invest Ophthalmol Vis Sci. 2019;60:1928-1936.
    PubMed     Text format     Abstract available


  5. DUMPALA S, Zele AJ, Feigl B
    Outer Retinal Structure and Function Deficits Contribute to Circadian Disruption in Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2019;60:1870-1878.
    PubMed     Text format     Abstract available


  6. LYNCH SK, Lee K, Chen Z, Folk JC, et al
    Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration.
    Invest Ophthalmol Vis Sci. 2019;60:2134-2139.
    PubMed     Text format     Abstract available


  7. MORJARIA R, Alexander I, Purbrick RMJ, Safa R, et al
    Impact of Diabetic Retinopathy on Sleep, Mood, and Quality of Life.
    Invest Ophthalmol Vis Sci. 2019;60:2304-2310.
    PubMed     Text format     Abstract available


  8. GRAUSLUND J, Frydkjaer-Olsen U, Peto T, Fernandez-Carneado J, et al
    Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
    Invest Ophthalmol Vis Sci. 2019;60:2257-2262.
    PubMed     Text format     Abstract available


  9. MILLER WP, Toro AL, Barber AJ, Dennis MD, et al
    REDD1 Activates a ROS-Generating Feedback Loop in the Retina of Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2019;60:2369-2379.
    PubMed     Text format     Abstract available


    April 2019
  10. FIGUERAS-ROCA M, Sala-Puigdollers A, Zarranz-Ventura J, Alba-Linero C, et al
    Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2019;60:1336-1343.
    PubMed     Text format     Abstract available


  11. BINOTTI WW, Romano AC
    Projection-Resolved Optical Coherence Tomography Angiography Parameters to Determine Severity in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:1321-1327.
    PubMed     Text format     Abstract available


  12. MORINO K, Murakami T, Dodo Y, Yasukura S, et al
    Characteristics of Diabetic Capillary Nonperfusion in Macular and Extramacular White Spots on Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2019;60:1595-1603.
    PubMed     Text format     Abstract available


  13. CUI RZ, Wang L, Qiao SN, Wang YC, et al
    ON-Type Retinal Ganglion Cells are Preferentially Affected in STZ-Induced Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2019;60:1644-1656.
    PubMed     Text format     Abstract available


  14. LIU H, Tang J, Du Y, Saadane A, et al
    Transducin1, Phototransduction and the Development of Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:1538-1546.
    PubMed     Text format     Abstract available


    March 2019
  15. ARCADU F, Benmansour F, Maunz A, Michon J, et al
    Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs.
    Invest Ophthalmol Vis Sci. 2019;60:852-857.
    PubMed     Text format     Abstract available


  16. LI T, Jia Y, Wang S, Wang A, et al
    Retinal Microvascular Abnormalities in Children with Type 1 Diabetes Mellitus Without Visual Impairment or Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:990-998.
    PubMed     Text format     Abstract available


    February 2019
  17. CUI Y, Yang X, Zhang G, Guo H, et al
    Intraocular Pressure in General and Diabetic Populations From Southern China: the Dongguan Eye Study.
    Invest Ophthalmol Vis Sci. 2019;60:761-769.
    PubMed     Text format     Abstract available


  18. ESHAQ RS, Harris NR
    Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix Metalloproteinases.
    Invest Ophthalmol Vis Sci. 2019;60:748-760.
    PubMed     Text format     Abstract available


  19. DMITRIEV AV, Henderson D, Linsenmeier RA
    Diabetes Alters pH Control in Rat Retina.
    Invest Ophthalmol Vis Sci. 2019;60:723-730.
    PubMed     Text format     Abstract available


  20. DEAK EA, Szalai E, Toth N, Malik RA, et al
    Longitudinal Changes in Corneal Cell and Nerve Fiber Morphology in Young Patients with Type 1 Diabetes with and without Diabetic Retinopathy: A 2-Year Follow-up Study.
    Invest Ophthalmol Vis Sci. 2019;60:830-837.
    PubMed     Text format     Abstract available


  21. SERGEYS J, Etienne I, Van Hove I, Lefevere E, et al
    Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses.
    Invest Ophthalmol Vis Sci. 2019;60:807-822.
    PubMed     Text format     Abstract available


  22. YOSHITAKE T, Murakami T, Yoshitake S, Suzuma K, et al
    Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2019;60:787-794.
    PubMed     Text format     Abstract available


    January 2019
  23. HU J, Hu X, Kan T
    MiR-34c Participates in Diabetic Corneal Neuropathy Via Regulation of Autophagy.
    Invest Ophthalmol Vis Sci. 2019;60:16-25.
    PubMed     Text format     Abstract available


  24. ALAMRI AS, Brock JA, Herath CB, Rajapaksha IG, et al
    The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal Epithelium.
    Invest Ophthalmol Vis Sci. 2019;60:209-217.
    PubMed     Text format     Abstract available


  25. ALLEN RS, Feola A, Motz CT, Ottensmeyer AL, et al
    Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2019;60:123-133.
    PubMed     Text format     Abstract available


  26. MCANANY JJ, Park JC
    Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.
    Invest Ophthalmol Vis Sci. 2019;60:64-72.
    PubMed     Text format     Abstract available


  27. ZHANG W, Wang Y, Kong Y
    Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1.
    Invest Ophthalmol Vis Sci. 2019;60:294-303.
    PubMed     Text format     Abstract available


    December 2018
  28. HAFNER J, Salas M, Scholda C, Vogl WD, et al
    Dynamic Changes of Retinal Microaneurysms in Diabetes Imaged With In Vivo Adaptive Optics Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2018;59:5932-5940.
    PubMed     Text format     Abstract available


  29. OZAKI K, Terayama Y, Matsuura T
    Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5868-5875.
    PubMed     Text format     Abstract available


  30. SONG B, Kim D, Nguyen NH, Roy S, et al
    Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5965-5972.
    PubMed     Text format     Abstract available


  31. YASUKURA S, Murakami T, Suzuma K, Yoshitake T, et al
    Diabetic Nonperfused Areas in Macular and Extramacular Regions on Wide-Field Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2018;59:5893-5903.
    PubMed     Text format     Abstract available


    November 2018
  32. JOLTIKOV KA, Sesi CA, de Castro VM, Davila JR, et al
    Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5481-5486.
    PubMed     Text format     Abstract available


  33. LIM SW, Bandala-Sanchez E, Kolic M, Rogers SL, et al
    The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5382-5390.
    PubMed     Text format     Abstract available


  34. LEE H, Chung H
    Author Response: Hyperreflective Intraretinal Foci as an OCT Biomarker of Retinal Inflammation in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5367.
    PubMed     Text format    


  35. MIDENA E, Pilotto E, Bini S
    Hyperreflective Intraretinal Foci as an OCT Biomarker of Retinal Inflammation in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5366.
    PubMed     Text format    


  36. LAMMER J, Karst SG, Lin MM, Cheney M, et al
    Association of Microaneurysms on Adaptive Optics Scanning Laser Ophthalmoscopy With Surrounding Neuroretinal Pathology and Visual Function in Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5633-5640.
    PubMed     Text format     Abstract available


  37. YOU ZP, Zhang YL, Li BY, Zhu XG, et al
    Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5558-5563.
    PubMed     Text format     Abstract available


  38. FERDOUSI M, Petropoulos IN, Kalteniece A, Azmi S, et al
    No Relation Between the Severity of Corneal Nerve, Epithelial, and Keratocyte Cell Morphology With Measures of Dry Eye Disease in Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5525-5530.
    PubMed     Text format     Abstract available


    October 2018
  39. VUJOSEVIC S, Muraca A, Gatti V, Masoero L, et al
    Peripapillary Microvascular and Neural Changes in Diabetes Mellitus: An OCT-Angiography Study.
    Invest Ophthalmol Vis Sci. 2018;59:5074-5081.
    PubMed     Text format     Abstract available


  40. JIN G, Xiao W, Ding X, Xu X, et al
    Prevalence of and Risk Factors for Diabetic Retinopathy in a Rural Chinese Population: The Yangxi Eye Study.
    Invest Ophthalmol Vis Sci. 2018;59:5067-5073.
    PubMed     Text format     Abstract available


  41. MCANANY JJ, Park JC
    Temporal Frequency Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Electroretinography.
    Invest Ophthalmol Vis Sci. 2018;59:4871-4879.
    PubMed     Text format     Abstract available


  42. DURAISAMY AJ, Mishra M, Kowluru A, Kowluru RA, et al
    Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:4831-4840.
    PubMed     Text format     Abstract available


    August 2018
  43. WANG N, Zou C, Zhao S, Wang Y, et al
    Fenofibrate Exerts Protective Effects in Diabetic Retinopathy via Inhibition of the ANGPTL3 Pathway.
    Invest Ophthalmol Vis Sci. 2018;59:4210-4217.
    PubMed     Text format     Abstract available


  44. ASHRAF M, Nesper PL, Jampol LM, Yu F, et al
    Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:4292-4298.
    PubMed     Text format     Abstract available


  45. NICHOLSON L, Crosby-Nwaobi R, Vasconcelos JC, Prevost AT, et al
    Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.
    Invest Ophthalmol Vis Sci. 2018;59:4277-4284.
    PubMed     Text format     Abstract available


    July 2018
  46. KALTENIECE A, Ferdousi M, Azmi S, Marshall A, et al
    Keratocyte Density Is Reduced and Related to Corneal Nerve Damage in Diabetic Neuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:3584-3590.
    PubMed     Text format     Abstract available


    June 2018
  47. SANDHU HS, Eltanboly A, Shalaby A, Keynton RS, et al
    Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2018;59:3155-3160.
    PubMed     Text format     Abstract available


    May 2018
  48. LU Y, Simonett JM, Wang J, Zhang M, et al
    Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2018;59:2212-2221.
    PubMed     Text format     Abstract available


  49. GALE JD, Berger B, Gilbert S, Popa S, et al
    A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:2659-2669.
    PubMed     Text format     Abstract available


  50. MCANANY JJ, Park JC
    Reduced Contrast Sensitivity is Associated With Elevated Equivalent Intrinsic Noise in Type 2 Diabetics Who Have Mild or No Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2652-2658.
    PubMed     Text format     Abstract available


  51. LIM RR, Grant DG, Olver TD, Padilla J, et al
    Young Ossabaw Pigs Fed a Western Diet Exhibit Early Signs of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2325-2338.
    PubMed     Text format     Abstract available


  52. SUNDSTROM JM, Hernandez C, Weber SR, Zhao Y, et al
    Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.
    Invest Ophthalmol Vis Sci. 2018;59:2264-2274.
    PubMed     Text format     Abstract available


    April 2018
  53. CHEN Q, Tan F, Wu Y, Zhuang X, et al
    Characteristics of Retinal Structural and Microvascular Alterations in Early Type 2 Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2018;59:2110-2118.
    PubMed     Text format     Abstract available


  54. NAHOMI RB, Sampathkumar S, Myers AM, Elghazi L, et al
    The Absence of Indoleamine 2,3-Dioxygenase Inhibits Retinal Capillary Degeneration in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:2042-2053.
    PubMed     Text format     Abstract available


  55. LEI J, Yi E, Suo Y, Chen C, et al
    Distinctive Analysis of Macular Superficial Capillaries and Large Vessels Using Optical Coherence Tomographic Angiography in Healthy and Diabetic Eyes.
    Invest Ophthalmol Vis Sci. 2018;59:1937-1943.
    PubMed     Text format     Abstract available


  56. LUO XY, Tan NYQ, Chee ML, Shi Y, et al
    Direct and Indirect Associations Between Diabetes and Intraocular Pressure: The Singapore Epidemiology of Eye Diseases Study.
    Invest Ophthalmol Vis Sci. 2018;59:2205-2211.
    PubMed     Text format     Abstract available


  57. ONISHI AC, Nesper PL, Roberts PK, Moharram GA, et al
    Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2167-2176.
    PubMed     Text format     Abstract available


    March 2018
  58. SCHORI C, Trachsel C, Grossmann J, Zygoula I, et al
    The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:AMD31-AMD40.
    PubMed     Text format     Abstract available


  59. GLASSMAN AR, Liu D, Jampol LM, Sun JK, et al
    Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1199-1205.
    PubMed     Text format     Abstract available


    February 2018
  60. DELIYANTI D, Alrashdi SF, Tan SM, Meyer C, et al
    Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:815-825.
    PubMed     Text format     Abstract available


  61. LEE H, Jang H, Choi YA, Kim HC, et al
    Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:715-721.
    PubMed     Text format     Abstract available


  62. CHEN H, Zhang X, Liao N, Mi L, et al
    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:978-985.
    PubMed     Text format     Abstract available


  63. CHEN X, Graham J, Petropoulos IN, Ponirakis G, et al
    Corneal Nerve Fractal Dimension: A Novel Corneal Nerve Metric for the Diagnosis of Diabetic Sensorimotor Polyneuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:1113-1118.
    PubMed     Text format     Abstract available


    January 2018
  64. WHITCUP SM, Cidlowski JA, Csaky KG, Ambati J, et al
    Pharmacology of Corticosteroids for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1-12.
    PubMed     Text format     Abstract available


  65. KIM MK, Aung MH, Mees L, Olson DE, et al
    Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:572-581.
    PubMed     Text format     Abstract available


  66. ABRAMOFF MD, Fort PE, Han IC, Jayasundera KT, et al
    Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:519-527.
    PubMed     Text format     Abstract available


    December 2017
  67. STUARD WL, Titone R, Robertson DM
    Tear Levels of Insulin-Like Growth Factor Binding Protein 3 Correlate With Subbasal Nerve Plexus Changes in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:6105-6112.
    PubMed     Text format     Abstract available


  68. LAGALI NS, Allgeier S, Guimaraes P, Badian RA, et al
    Reduced Corneal Nerve Fiber Density in Type 2 Diabetes by Wide-Area Mosaic Analysis.
    Invest Ophthalmol Vis Sci. 2017;58:6318-6327.
    PubMed     Text format     Abstract available


  69. GUYON B, Elphege E, Flores M, Gauthier AS, et al
    Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME).
    Invest Ophthalmol Vis Sci. 2017;58:6241-6247.
    PubMed     Text format     Abstract available


  70. DURAISAMY AJ, Mishra M, Kowluru RA
    Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6440-6448.
    PubMed     Text format     Abstract available


  71. FENWICK EK, Khadka J, Pesudovs K, Rees G, et al
    Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing.
    Invest Ophthalmol Vis Sci. 2017;58:6379-6387.
    PubMed     Text format     Abstract available


  72. SRINIVASAN S, Dehghani C, Pritchard N, Edwards K, et al
    Corneal and Retinal Neuronal Degeneration in Early Stages of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6365-6373.
    PubMed     Text format     Abstract available


  73. ZHANG SJ, Chen X, Li CP, Li XM, et al
    Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6500-6509.
    PubMed     Text format     Abstract available


  74. MITCHELL SL, Neininger AC, Bruce CN, Chocron IM, et al
    Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6481-6488.
    PubMed     Text format     Abstract available


    November 2017
  75. WEI Q, Zhang T, Jiang R, Chang Q, et al
    Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
    Invest Ophthalmol Vis Sci. 2017;58:5783-5791.
    PubMed     Text format     Abstract available


  76. DODO Y, Murakami T, Suzuma K, Yoshitake S, et al
    Diabetic Neuroglial Changes in the Superficial and Deep Nonperfused Areas on Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:5870-5879.
    PubMed     Text format     Abstract available


  77. SRINIVASAN S, Raman R, Swaminathan G, Ganesan S, et al
    Incidence, Progression, and Risk Factors for Cataract in Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5921-5929.
    PubMed     Text format     Abstract available


  78. HWANG HS, Chae JB, Kim JY, Kim DY, et al
    Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Invest Ophthalmol Vis Sci. 2017;58:5958-5967.
    PubMed     Text format     Abstract available


    October 2017
  79. OMAE T, Nagaoka T, Yoshida A
    Effect of Circulating Omentin-1 on the Retinal Circulation in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:5086-5092.
    PubMed     Text format     Abstract available


  80. HU P, Hunt NH, Arfuso F, Shaw LC, et al
    Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Muller Cells of Diabetic Human and Rodent Retina.
    Invest Ophthalmol Vis Sci. 2017;58:5043-5055.
    PubMed     Text format     Abstract available


  81. DENG G, Moran EP, Cheng R, Matlock G, et al
    Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5030-5042.
    PubMed     Text format     Abstract available


  82. BOSS JD, Singh PK, Pandya HK, Tosi J, et al
    Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5594-5603.
    PubMed     Text format     Abstract available


  83. BLAIR NP, Wanek J, Felder AE, Joslin CE, et al
    Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5556-5563.
    PubMed     Text format     Abstract available


  84. HAFNER J, Ginner L, Karst S, Leitgeb R, et al
    Regional Patterns of Retinal Oxygen Saturation and Microvascular Hemodynamic Parameters Preceding Retinopathy in Patients With Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5541-5547.
    PubMed     Text format     Abstract available


    September 2017
  85. DI G, Qi X, Zhao X, Zhang S, et al
    Corneal Epithelium-Derived Neurotrophic Factors Promote Nerve Regeneration.
    Invest Ophthalmol Vis Sci. 2017;58:4695-4702.
    PubMed     Text format     Abstract available


  86. FERNANDEZ-BUENO I, Jones R, Soriano-Romani L, Lopez-Garcia A, et al
    Histologic Characterization of Retina Neuroglia Modifications in Diabetic Zucker Diabetic Fatty Rats.
    Invest Ophthalmol Vis Sci. 2017;58:4925-4933.
    PubMed     Text format     Abstract available


  87. KAIZU Y, Nakao S, Yoshida S, Hayami T, et al
    Optical Coherence Tomography Angiography Reveals Spatial Bias of Macular Capillary Dropout in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:4889-4897.
    PubMed     Text format     Abstract available


  88. BRAZIER J, Muston D, Konwea H, Power GS, et al
    Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
    Invest Ophthalmol Vis Sci. 2017;58:4818-4825.
    PubMed     Text format     Abstract available


    May 2017
  89. JOLTIKOV KA, de Castro VM, Davila JR, Anand R, et al
    Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:BIO277-BIO290.
    PubMed     Text format     Abstract available


  90. NESPER PL, Roberts PK, Onishi AC, Chai H, et al
    Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:BIO307-BIO315.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: